Brain Metastases from Primary Tumors, Volume 2: Epidemiology, Biology, and Therapy
Editat de M. A. Hayaten Limba Engleză Hardback – 4 ian 2015
- The only comprehensive reference detailing the link between primary cancers and brain metastases
- Aids the target audience in determining the incidence of brain metastases in patients with a primary cancer
- Provides education about the potential use of biomarkers for early detection, diagnosis and prevention of the spread of primary cancer to the brain
- Documents temporal and gender-related trends in brain metastases from other cancers
- Edited work with chapters authored by leaders in the field around the globe – the broadest, most expert coverage available
- The only comprehensive reference detailing the link between primary cancers and brain metastases
Preț: 637.77 lei
Preț vechi: 671.34 lei
-5% Nou
Puncte Express: 957
Preț estimativ în valută:
122.06€ • 126.78$ • 101.39£
122.06€ • 126.78$ • 101.39£
Carte tipărită la comandă
Livrare economică 27 ianuarie-10 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128014196
ISBN-10: 0128014199
Pagini: 236
Dimensiuni: 191 x 235 x 18 mm
Greutate: 0.7 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128014199
Pagini: 236
Dimensiuni: 191 x 235 x 18 mm
Greutate: 0.7 kg
Editura: ELSEVIER SCIENCE
Public țintă
Academic/clinical professors, post-doctoral fellows, graduate and medical students in neuro-oncology, oncology, cancer research, pathology, reproductive oncologyCuprins
I. GENERAL APPLICATIONS1. Brain Metastasis from Solid Tumors2. The Role of Surgical Resection for Metastatic Brain Tumors3. Whole Brain Radiotherapy for Brain Metastases: Is the Therapeutic Window Enlarging?
II. NON-SMALL CELL LUNG CANCER4. Brain Metastasis in Patients with Non-Small Cell Lung Cancer: Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor5. Brain Metastasis from Non-Small Cell Lung Cancer: Use of Egfr and Her-2 Status for Targeted Therapy6. Brain Metastases from Non-Small Cell Lung Cancer: Current Evidence in Management Using Tyrosine Kinase Inhibitor and Whole Brain Radiation Therapy7. Brain Metastasis in Patients with Non-Small Cell Lung Cancer: Immunohistochemical Markers
III. BREAST CANCER8. Brain Metastasis from Breast Cancer: Molecular Mechanisms9. New Targeted Therapies for Brain Metastasis from Breast and Lung Cancer and Melanoma10. Breast Cancers with Brain Metastases
IV. MELANOMA11. Brain Metastases in Melanoma Patients: Treatment with Adjuvant Postoperative Whole Brain Radiotherapy12. Melanoma Progression in the Brain: Role of Pericytes, the Basal Lamina, and Endothelial Cells in Tumor Vascularization
V. ESOPHAGEAL CANCER13. Brain Metastases from Esophageal Cancer in the Presence of Her-2 Overexpression
VI. RENAL CARCINOMA14. Brain Metastasis from Renal Carcinoma: Locoregional and Systemic Treatments
VII. GASTROINTESTINAL CANCER15. Gastrointestinal Cancer and Brain Metastasis Outcomes and Management
VIII. COLORECTAL CANCER16. Brain Metastasis of Colorectal Cancer: Microenvironment and Molecular Mechanism
IX. NASOPHARYNGEAL CARCINOMA17. Brain Metastasis from Nasopharyngeal Carcinoma
II. NON-SMALL CELL LUNG CANCER4. Brain Metastasis in Patients with Non-Small Cell Lung Cancer: Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor5. Brain Metastasis from Non-Small Cell Lung Cancer: Use of Egfr and Her-2 Status for Targeted Therapy6. Brain Metastases from Non-Small Cell Lung Cancer: Current Evidence in Management Using Tyrosine Kinase Inhibitor and Whole Brain Radiation Therapy7. Brain Metastasis in Patients with Non-Small Cell Lung Cancer: Immunohistochemical Markers
III. BREAST CANCER8. Brain Metastasis from Breast Cancer: Molecular Mechanisms9. New Targeted Therapies for Brain Metastasis from Breast and Lung Cancer and Melanoma10. Breast Cancers with Brain Metastases
IV. MELANOMA11. Brain Metastases in Melanoma Patients: Treatment with Adjuvant Postoperative Whole Brain Radiotherapy12. Melanoma Progression in the Brain: Role of Pericytes, the Basal Lamina, and Endothelial Cells in Tumor Vascularization
V. ESOPHAGEAL CANCER13. Brain Metastases from Esophageal Cancer in the Presence of Her-2 Overexpression
VI. RENAL CARCINOMA14. Brain Metastasis from Renal Carcinoma: Locoregional and Systemic Treatments
VII. GASTROINTESTINAL CANCER15. Gastrointestinal Cancer and Brain Metastasis Outcomes and Management
VIII. COLORECTAL CANCER16. Brain Metastasis of Colorectal Cancer: Microenvironment and Molecular Mechanism
IX. NASOPHARYNGEAL CARCINOMA17. Brain Metastasis from Nasopharyngeal Carcinoma